期刊文献+

经皮肾动脉成形术或支架植入术治疗肾动脉狭窄65例临床分析 被引量:1

Percutaneous transluminal balloon angioplasty or stenting for renal stenosis in 65 cases
原文传递
导出
摘要 目的探讨肾动脉狭窄临床特点及经皮肾动脉成形术或支架植入术治疗效果。方法肾动脉狭窄患者65例中动脉粥样硬化型50例,大动脉炎型7例,肌纤维发育不良型8例;合并1~3级高血压或难治性高血压61例;均行经皮肾动脉成形术或经皮。肾动脉支架植入术治疗。结果术中造影显示65例肾动脉狭窄程度达70~90(81.5±11.3)%,其中位于肾动脉开口处病变54例,肾动脉中段病变8例,肾动脉全段狭窄3例;59例顺利完成腔内治疗,其中行经皮肾动脉成形术13例,行经皮肾动脉支架植人术46例,余6例因。肾动脉狭窄程度重,术中扩张狭窄段出现较强球囊扩张抵抗而未完成腔内治疗;术后患者血压((130.5士12.9)/(79.8±9.1)mmHg)较术前((178.9±27.7)/(113.7±25.8)mmHg)明显下降(t=15.307,P〈0.01),高血压治疗有效率62.3%,术后肾功能改善率和稳定率分别达到9.4%和86.8%。结论肾动脉狭窄主要表现为难治性高血压,临床应针对不同病因采取不同腔内治疗方法。 Objective To investigate clinical features of renal stenosis and therapeutic effect of percutaneous transluminal balloon angioplasty or stenting. Methods In 65 cases of renal stenosis, there were 50 cases of atherosclerosis, 7 of Takayasu arteritis and 8 of fibromuscular dysplasia. Hypertension in grade I to Ⅲ or refractory hypertension was found in 61 cases. All cases were treated with percutaneous transIuminal balloon angioplasty (PBTA) or percutaneous transluminal renal artery stenting (PTRAS). Results Intraoperative angiography showed 70 to 90 (81.5±11.3)% of renal artery stenosis in 65 cases, in which the stenosis segment in renal artery was located in the proximal, middle and whole renal artery in 54, 8 and 3 cases respectively. Fifty-nine cases were successfully performed endovasculartreatment, in which PTBA was performed in 13 cases and PTRAS in 46 cases. Six cases failed to fulfill endovascular treatment due to severe renal artery stenosis and resistance to balloon expansion. The blood pressure decreased from (178. 9±27. 7)/ (113.7±25.8) mm Hg before operation to (130.5±12.9)/(79.8±9.1) mm Hg after operation (t=15. 307, P〈0.01), with the effective rate of 62.3%. The improvement rate and stable rate of postoperative renal function were 9.4% and 86.8%, respectively. Conclusions Renal artery stenosis is mainly manifested as refractory hypertension, and the patients should be given corresponding endovascular treatment based on different causes.
出处 《中华实用诊断与治疗杂志》 2014年第4期385-387,共3页 Journal of Chinese Practical Diagnosis and Therapy
关键词 肾动脉狭窄 腔内治疗 经皮肾动脉成形术 经皮肾动脉支架植入术 Renal stenosis endovascular treatment percutaneous transluminal balloon angioplasty percutaneoustransluminal renal artery stenting
  • 相关文献

参考文献10

  • 1Edwards M S, Hansen K J, Craven T E, et al. Relationships between renovascular disease, blood pressure, and renal function in the elderly: a population-based study[J]. Am J Kidney Dis, 2003,41(5) :990 -996.
  • 2Zeller T, Frank U, Mtiller C, et al. Predictors of improved renal function after percutaneous stent-supported angioplasty of atheroselerotic ostial renal artery stenosis [ J ]. Circulation, 2003,108(18) = 2244-2249.
  • 3Rundback J H, Sacks D, Kent K C, et al. Guidelines for the reporting of renal artery revascularization in clinical trials[J]. Circulation, 2002,106 (12) : 1572-1585.
  • 4Nakamura S, Iihara K, Matayoshi T, et al. The incidence and risk factors of renal artery stenosis in patients with severe carotid artery stenosis[J]. Hypertens Res, 2007,30 (9) : 839-844.
  • 5Caps M T, Perissinotto C, Zierler R E, etal. Prospective study of atherosclerotic disease progression in the renal artery [J]. Circulation, 1998,98(25) : 2866-2872.
  • 6Chabova V, Schirger A, Stanson A W, et al. Outcomes of atherosclerotic renal artery stenosis managed without revascularization[J]. Mayo Clin Proc, 2000,75 (5) : 437-444.
  • 7吴哲兵,代升平,魏运亮,潘金生,丰冠鹏,宗书峰,赵丹丹.多发性大动脉炎累及冠状动脉1例报道[J].中华实用诊断与治疗杂志,2012,26(7):726-727. 被引量:1
  • 8符春晖,严华,陆永光,陈湘桂,黄军章.原发性高血压病患者肾素-血管紧张素-醛固酮系统活性的影响因素[J].中华实用诊断与治疗杂志,2011,25(7):633-635. 被引量:22
  • 9Nolan B W, Schermerhorn M L, Rowell E, etal. Outcomes of renal artery angioplasty and stenting using low-profile systems [J]. J VascSurg,2005,41(1)=46-52.
  • 10Rocha-Singh K J, Ahuja R K, Sung C H, et al. Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy[J]. Catheter Cardiovasc Interv,2002,57(2) :135 -141.

二级参考文献15

  • 1杨海芸,曹国良.不同剂量辛伐他汀对高血压病患者血管活性物质水平的影响[J].实用诊断与治疗杂志,2007,21(1):20-22. 被引量:18
  • 2中华人民共和国卫生部疾病控制司.中国成人超重和肥胖症预防与控制指南[M].北京:人民卫生出版社,2006.
  • 3Grobe J l., Mecca A P, Lingis M, et al. Prevention of angiotensin Ⅱ induced cardiac remodeling by angiotensin (1 7) [J]. AmJ Physiol Heart CircPhysiol,2007,292(2):H736-742.
  • 4Jiang X, Sheng H, Li J, et al. Association between rennin angiotensin system gene polymorphism and essential hypertension: a community based study[J]. J Hum Hypertens, 2009,23(3) :176-181.
  • 5Jeunemaitre X. Genetics of the human renin angiotensin system [J]. J Mol Med,2008,86(6):637-641.
  • 6Hansen T W, Li Y, Boggia J, et al. Predictive role of the nighttime blood pressure[J]. Hypertension,2011,57(1) :3-10.
  • 7Hermida R C, Ayala D E, Fernandez J R, et al. Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications [J]. AmJ Hypertens,2011,24(4):383-391.
  • 8Johansson J K, Niiranen T J, Puukka P J, et al. Factors affecting the variability of home-measured blood pressure and heart rate: the Finn home study[J]. J Hypertens,2010,28(9): 1836-1845.
  • 9Yuan W, Pan W, Kong J, et al. 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter [J]. J BiolChem,2007,282(41):29821-29830.
  • 10Numano F, Okawara M, Inomata H, etal. Takayasu's arteritis[J]. Lancet,2000,356(9234):1023-1025.

共引文献21

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部